124 related articles for article (PubMed ID: 37608429)
1. Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics.
Maynard RD; Funk T; Harrill W; Jin J; Smith D; Smith G; Korpi-Steiner N
J Appl Lab Med; 2023 Nov; 8(6):1028-1041. PubMed ID: 37608429
[TBL] [Abstract][Full Text] [Related]
2. The HemoScreen hematology point-of-care device is suitable for rapid evaluation of acute leukemia patients.
Kristian Kur D; Thøgersen D; Kjeldsen L; Friis-Hansen L
Int J Lab Hematol; 2021 Feb; 43(1):52-60. PubMed ID: 32894640
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of a new compact hematology analyzer, the Sysmex pocH-100i.
Briggs C; Kunka S; Pennaneach C; Forbes L; Machin SJ
Lab Hematol; 2003; 9(4):225-33. PubMed ID: 14649465
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of the Sysmex pocH-100i automated hematology analyzer.
Whisler S; Dahlgren C
Lab Hematol; 2005; 11(2):107-17. PubMed ID: 16024334
[TBL] [Abstract][Full Text] [Related]
5. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
6. An artificial intelligence-assisted diagnostic platform for rapid near-patient hematology.
Bachar N; Benbassat D; Brailovsky D; Eshel Y; Glück D; Levner D; Levy S; Pecker S; Yurkovsky E; Zait A; Sever C; Kratz A; Brugnara C
Am J Hematol; 2021 Oct; 96(10):1264-1274. PubMed ID: 34264525
[TBL] [Abstract][Full Text] [Related]
7. The HemoScreen, a novel haematology analyser for the point of care.
Ben-Yosef Y; Marom B; Hirshberg G; D'Souza C; Larsson A; Bransky A
J Clin Pathol; 2016 Aug; 69(8):720-5. PubMed ID: 26786235
[TBL] [Abstract][Full Text] [Related]
8. HemoScreen hematology analyzer compared to Sysmex XN for complete blood count, white blood cell differential, and detection of leukocyte abnormalities.
Linko-Parvinen AM; Keränen K; Kurvinen K; Tienhaara A
EJHaem; 2022 Nov; 3(4):1126-1134. PubMed ID: 36467845
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and patient-reported satisfaction using a novel point-of-care fingerstick method for monitoring absolute neutrophil count for clozapine.
Kelly DL; Ponomareva OY; Mackowick M; Glassman M; Park J; Navarro-De La Vega M; Wehring HJ; Vyas G
Ann Clin Psychiatry; 2021 May; 33(2):116-123. PubMed ID: 33878286
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.
Richardson CM; Davis EA; Vyas GR; DiPaula BA; McMahon RP; Kelly DL
J Clin Psychiatry; 2016 Nov; 77(11):e1454-e1459. PubMed ID: 27736047
[TBL] [Abstract][Full Text] [Related]
11. Haematological point of care testing for clozapine monitoring.
Atkins M; McGuire P; Balgobin B; Desouza N; Taylor D
J Psychiatr Res; 2023 Jan; 157():66-71. PubMed ID: 36442408
[TBL] [Abstract][Full Text] [Related]
12. Risk of neutropenia among clozapine users and non-users: results from 5,847 patients.
Goldani AAS; Rabelo-da-Ponte FD; Feiten JG; Lobato MIR; Belmonte-de-Abreu PS; Gama CS
Braz J Psychiatry; 2022; 44(1):21-25. PubMed ID: 34730717
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection.
Moga S; Teodorescu A; Ifteni P; Petric PS; Miron AA
Neuropsychiatr Dis Treat; 2022; 18():977-983. PubMed ID: 35547265
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Sysmex pocH-1001 haematology analyser in an outdoor oncology service.
Van Hecke I; Vanden Bempt I; Malfait R; Van Den Bossche J
Acta Clin Belg; 2010; 65(4):248-51. PubMed ID: 20954464
[TBL] [Abstract][Full Text] [Related]
15. XW-100: First FDA CLIA-Waived CBC Analyzer Designed for Physician Office Use.
Wu AHB; Sellers J
J Appl Lab Med; 2019 Mar; 3(5):839-846. PubMed ID: 31639758
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.
Maher KN; Tan M; Tossell JW; Weisinger B; Gochman P; Miller R; Greenstein D; Overman GP; Rapoport JL; Gogtay N
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):110-6. PubMed ID: 23510445
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of the Sysmex pocH-100iV Diff hematology analyzer for analysis of canine, feline, equine, and bovine blood.
Riond B; Weissenbacher S; Hofmann-Lehmann R; Lutz H
Vet Clin Pathol; 2011 Dec; 40(4):484-495. PubMed ID: 22092369
[TBL] [Abstract][Full Text] [Related]
18. Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals.
Oloyede E; Dzahini O; Barnes N; Mijovic A; Gandhi S; Stuart-Smith S; de Witte T; Taylor D; Whiskey E
BMC Psychiatry; 2021 Oct; 21(1):502. PubMed ID: 34645395
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical study of canine and feline total blood cell count results with seven in-clinic and two commercial laboratory hematology analyzers.
Becker M; Moritz A; Giger U
Vet Clin Pathol; 2008 Dec; 37(4):373-84. PubMed ID: 19055571
[TBL] [Abstract][Full Text] [Related]
20. Measurement of CD4+ T cells in point-of-care settings with the Sysmex pocH-100i haematological analyser.
Briggs C; Machin S; Müller M; Haase W; Hofmann K; Forstreuter F; Hinzmann R
Int J Lab Hematol; 2009 Apr; 31(2):169-79. PubMed ID: 18177434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
